These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26666582)

  • 1. Evaluating thermodynamic integration performance of the new amber molecular dynamics package and assess potential halogen bonds of enoyl-ACP reductase (FabI) benzimidazole inhibitors.
    Su PC; Johnson ME
    J Comput Chem; 2016 Apr; 37(9):836-47. PubMed ID: 26666582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of radii sets, entropy, QM methods, and sampling on MM-PBSA, MM-GBSA, and QM/MM-GBSA ligand binding energies of F. tularensis enoyl-ACP reductase (FabI).
    Su PC; Tsai CC; Mehboob S; Hevener KE; Johnson ME
    J Comput Chem; 2015 Sep; 36(25):1859-73. PubMed ID: 26216222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of absolute configuration and binding efficacy of benzimidazole-based FabI inhibitors through the support of electronic circular dichroism and MM-GBSA techniques.
    Ren J; Mistry TL; Su PC; Mehboob S; Demissie R; Fung LW; Ghosh AK; Johnson ME
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2074-2079. PubMed ID: 29730028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and biological evaluation of a novel series of benzimidazole inhibitors of Francisella tularensis enoyl-ACP reductase (FabI).
    Mehboob S; Song J; Hevener KE; Su PC; Boci T; Brubaker L; Truong L; Mistry T; Deng J; Cook JL; Santarsiero BD; Ghosh AK; Johnson ME
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1292-6. PubMed ID: 25677657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism-directed structure optimization of benzimidazole-based Francisella tularensis enoyl-reductase (FabI) inhibitors.
    Zhang YY; Liu Y; Mehboob S; Song JH; Boci T; Johnson ME; Ghosh AK; Jeong H
    Xenobiotica; 2014 May; 44(5):404-16. PubMed ID: 24171690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzimidazole-Based FabI Inhibitors: A Promising Novel Scaffold for Anti-staphylococcal Drug Development.
    Mistry TL; Truong L; Ghosh AK; Johnson ME; Mehboob S
    ACS Infect Dis; 2017 Jan; 3(1):54-61. PubMed ID: 27756129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a novel and potent class of F. tularensis enoyl-reductase (FabI) inhibitors by molecular shape and electrostatic matching.
    Hevener KE; Mehboob S; Su PC; Truong K; Boci T; Deng J; Ghassemi M; Cook JL; Johnson ME
    J Med Chem; 2012 Jan; 55(1):268-79. PubMed ID: 22098466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and enzymatic analyses reveal the binding mode of a novel series of Francisella tularensis enoyl reductase (FabI) inhibitors.
    Mehboob S; Hevener KE; Truong K; Boci T; Santarsiero BD; Johnson ME
    J Med Chem; 2012 Jun; 55(12):5933-41. PubMed ID: 22642319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Francisella tularensis FabI enoyl-acyl carrier protein reductase gene is essential to bacterial viability and is expressed during infection.
    Kingry LC; Cummings JE; Brookman KW; Bommineni GR; Tonge PJ; Slayden RA
    J Bacteriol; 2013 Jan; 195(2):351-8. PubMed ID: 23144254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA.
    Bergler H; Fuchsbichler S; Högenauer G; Turnowsky F
    Eur J Biochem; 1996 Dec; 242(3):689-94. PubMed ID: 9022698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of inhibitor aliphatic chain in the thermodynamics of inhibitor binding to Escherichia coli enoyl-ACP reductase and the Phe203Leu mutant: a proposed mechanism for drug resistance.
    Protasevich II; Brouillette CG; Snow ME; Dunham S; Rubin JR; Gogliotti R; Siegel K
    Biochemistry; 2004 Oct; 43(42):13380-9. PubMed ID: 15491144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative inhibition studies of enoyl-CoA hydratase 1 and enoyl-CoA hydratase 2 in long-chain fatty acid oxidation.
    Wu L; Lin S; Li D
    Org Lett; 2008 Aug; 10(15):3355-8. PubMed ID: 18611036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional expression of Francisella tularensis FabH and FabI, potential antibacterial targets.
    Wen L; Chmielowski JN; Bohn KC; Huang JK; Timsina YN; Kodali P; Pathak AK
    Protein Expr Purif; 2009 May; 65(1):83-91. PubMed ID: 19095065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow-onset inhibition of the FabI enoyl reductase from francisella tularensis: residence time and in vivo activity.
    Lu H; England K; am Ende C; Truglio JJ; Luckner S; Reddy BG; Marlenee NL; Knudson SE; Knudson DL; Bowen RA; Kisker C; Slayden RA; Tonge PJ
    ACS Chem Biol; 2009 Mar; 4(3):221-31. PubMed ID: 19206187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theoretical study on the chemical mechanism of enoyl-CoA hydratase and the form of inhibitor binding.
    Cui X; He R; Yang Q; Shen W; Li M
    J Mol Model; 2014 Sep; 20(9):2411. PubMed ID: 25174944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the Efficiency of Free Energy Calculations in the Amber Molecular Dynamics Package.
    Kaus JW; Pierce LT; Walker RC; McCammont JA
    J Chem Theory Comput; 2013 Sep; 9(9):. PubMed ID: 24185531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMBER empirical potential describes the geometry and energy of noncovalent halogen interactions better than advanced semiempirical quantum mechanical method PM6-DH2X.
    Ibrahim MA
    J Phys Chem B; 2012 Mar; 116(11):3659-69. PubMed ID: 22393912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The benzimidazole based drugs show good activity against T. gondii but poor activity against its proposed enoyl reductase enzyme target.
    Wilkinson C; McPhillie MJ; Zhou Y; Woods S; Afanador GA; Rawson S; Khaliq F; Prigge ST; Roberts CW; Rice DW; McLeod R; Fishwick CW; Muench SP
    Bioorg Med Chem Lett; 2014 Feb; 24(3):911-6. PubMed ID: 24398298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Modelling Study and Antibacterial Evaluation of Diphenylmethane Derivatives as Potential FabI Inhibitors.
    Hasan S; Kayed K; Ghemrawi R; Bataineh NA; Mahgoub RE; Audeh R; Aldulaymi R; Atatreh N; Ghattas MA
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast and flexible gpu accelerated binding free energy calculations within the amber molecular dynamics package.
    Mermelstein DJ; Lin C; Nelson G; Kretsch R; McCammon JA; Walker RC
    J Comput Chem; 2018 Jul; 39(19):1354-1358. PubMed ID: 29532496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.